HCM
CMD

Highbridge Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Highbridge Capital Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-9,396
Closed -$211K – 1591
2013
Q2 		$211K Buy
+9,396
New +$203K ﹤0.01% 1166

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Highbridge Capital Management's CMD Position: Q3 2013 in Review

Highbridge Capital Management sold out of Cantel Medical Corporation (CMD) in Q3 2013, closing a stake of 9,396 shares — an estimated $211K sold.

Highbridge Capital Management first reported a position in CMD in Q2 2013 and held it in 1 quarter. The position peaked at $211K in Q2 2013. 133 funds tracked by Wall St. Rank hold CMD as of Q3 2013.

  • Highbridge Capital Management reported no remaining Cantel Medical Corporation position as of Q3 2013 after selling out during the quarter.
  • Highbridge Capital Management sold 9,396 Cantel Medical Corporation shares in Q3 2013, an estimated $211K.
  • Highbridge Capital Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 1 quarter.
  • Highbridge Capital Management's Cantel Medical Corporation position peaked at $211K in Q2 2013.
  • 133 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2013.

Based on Highbridge Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.